← All Investors
STANDARD BIOTOOLS INC
LAB
Holders
1
Combined Value
$53.92M
Combined Shares
58,651,170
Current Price
$0.89
52W High
$1.72
vs 52W High
−48.4%
Investor Activity Chart
Quarterly buys (▲) and sells (▼) by tracked investors. Click a marker to view that investor's portfolio; hover for details. Price line is implied from 13F filings (value ÷ shares), not market data.
Held By
Tracked investors currently holding this security, based on each investor's most recent 13F filing. Gain compares the current market price to each investor's estimated average buy price.
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Andreas Halvorsen - Viking Global Investors | $53.92M | 0.15% | ~$1.77 | −49.8% | BUY Q2 2024 | Q1 2026 |
Recent Activity
Latest position changes by tracked investors. Prices are estimates implied from 13F filings.
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q4 2024 | Jim Simons - Renaissance Technologies | SOLD OUT | −$387.9K | ~$1.93 |
| Q3 2024 | Jim Simons - Renaissance Technologies | SELL | −$1.55M | ~$1.93 |
| Q2 2024 | Andreas Halvorsen - Viking Global Investors | NEW BUY | +$103.81M | ~$1.77 |
| Q2 2024 | Jim Simons - Renaissance Technologies | NEW BUY | +$1.78M | ~$1.77 |
Ownership History
Aggregate position across all tracked investors per quarter (options excluded). Implied price is the reported value divided by shares held.
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 1 | 58,651,170 | UNCH | $53.92M | $0.92 |
| Q4 2025 | 1 | 58,651,170 | UNCH | $75.07M | $1.28 |
| Q3 2025 | 1 | 58,651,170 | UNCH | $76.25M | $1.30 |
| Q2 2025 | 1 | 58,651,170 | UNCH | $70.38M | $1.20 |
| Q1 2025 | 1 | 58,651,170 | UNCH | $63.34M | $1.08 |
| Q4 2024 | 1 | 58,651,170 | -0.3% | $102.64M | $1.75 |
| Q3 2024 | 2 | 58,852,170 | -1.3% | $113.58M | $1.93 |
| Q2 2024 | 2 | 59,655,728 | — | $105.59M | $1.77 |